Connell, C. M., Shibata, A., Tookman, L. A., Archibald, K. M., Flak, M. B., Pirlo, K. J., . . . McNeish, I. A. (2011). Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells. American Society for Clinical Investigation.
Citação norma ChicagoConnell, Claire M., Atsushi Shibata, Laura A. Tookman, Kyra M. Archibald, Magdalena B. Flak, Katrina J. Pirlo, Michelle Lockley, Sally P. Wheatley, and Iain A. McNeish. Genomic DNA Damage and ATR-Chk1 Signaling Determine Oncolytic Adenoviral Efficacy in Human Ovarian Cancer Cells. American Society for Clinical Investigation, 2011.
MLA citiranjeConnell, Claire M., et al. Genomic DNA Damage and ATR-Chk1 Signaling Determine Oncolytic Adenoviral Efficacy in Human Ovarian Cancer Cells. American Society for Clinical Investigation, 2011.